These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33222944)

  • 1. Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis.
    Cottrill E; Premananthan C; Pennington Z; Ehresman J; Theodore N; Sciubba DM; Witham T
    J Clin Neurosci; 2020 Nov; 81():353-366. PubMed ID: 33222944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumbar interbody fusion rates with 3D-printed lamellar titanium cages using a silicate-substituted calcium phosphate bone graft.
    Mokawem M; Katzouraki G; Harman CL; Lee R
    J Clin Neurosci; 2019 Oct; 68():134-139. PubMed ID: 31351704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an increased strut porosity silicate-substituted calcium phosphate, SiCaP EP, as a synthetic bone graft substitute in spinal fusion surgery: a prospective, open-label study.
    Bolger C; Jones D; Czop S
    Eur Spine J; 2019 Jul; 28(7):1733-1742. PubMed ID: 30834972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
    Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
    J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silicate-substituted calcium phosphate ceramic bone graft replacement for spinal fusion procedures.
    Nagineni VV; James AR; Alimi M; Hofstetter C; Shin BJ; Njoku I; Tsiouris AJ; Härtl R
    Spine (Phila Pa 1976); 2012 Sep; 37(20):E1264-72. PubMed ID: 22744618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiographic and Clinical Outcome of Silicate-substituted Calcium Phosphate (Si-CaP) Ceramic Bone Graft in Spinal Fusion Procedures.
    Alimi M; Navarro-Ramirez R; Parikh K; Njoku I; Hofstetter CP; Tsiouris AJ; Härtl R
    Clin Spine Surg; 2017 Jul; 30(6):E845-E852. PubMed ID: 27623299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.
    Parker RM; Malham GM
    Eur Spine J; 2017 Mar; 26(3):754-763. PubMed ID: 28028645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective, Randomized, Multicenter Study Comparing Silicated Calcium Phosphate versus BMP-2 Synthetic Bone Graft in Posterolateral Instrumented Lumbar Fusion for Degenerative Spinal Disorders.
    Coughlan M; Davies M; Mostert AK; Nanda D; Willems PC; Rosenberg G; Ferch R
    Spine (Phila Pa 1976); 2018 Aug; 43(15):E860-E868. PubMed ID: 29652784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV; Marquez-Lara A; Fineberg SJ; Pelton M; Singh K
    Spine (Phila Pa 1976); 2014 Feb; 39(3):185-91. PubMed ID: 24253788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing strut porosity in silicate-substituted calcium-phosphate bone graft substitutes enhances osteogenesis.
    Campion CR; Chander C; Buckland T; Hing K
    J Biomed Mater Res B Appl Biomater; 2011 May; 97(2):245-54. PubMed ID: 21384544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix/P-15 composite.
    Mobbs RJ; Maharaj M; Rao PJ
    J Neurosurg Spine; 2014 Dec; 21(6):867-76. PubMed ID: 25325176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of SiCaP-30 in a Rabbit Posterolateral Fusion Model with Concurrent Chemotherapy.
    Smucker JD; Petersen EB; Al-Hili A; Nepola JV; Fredericks DC
    Iowa Orthop J; 2015; 35():140-6. PubMed ID: 26361457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Silicate-Substituted Calcium Phosphate (Actifuse) with Recombinant Human Bone Morphogenetic Protein-2 (Infuse) in Posterolateral Instrumented Lumbar Fusion.
    Licina P; Coughlan M; Johnston E; Pearcy M
    Global Spine J; 2015 Dec; 5(6):471-8. PubMed ID: 26682097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of increased microporosity on bone formation within silicate-substituted scaffolds in an ovine posterolateral spinal fusion model.
    Coathup MJ; Blunn GW; Campion C; Ho CY; Hing KA
    J Biomed Mater Res B Appl Biomater; 2017 May; 105(4):805-814. PubMed ID: 28402086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of benign bone defects in children with silicate-substituted calcium phosphate (SiCaP).
    Kirschner HJ; Obermayr F; Schaefer J; Lieber J
    Eur J Pediatr Surg; 2012 Apr; 22(2):143-7. PubMed ID: 22517522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of silicate-substituted calcium phosphate with enhanced strut porosity as a standalone bone graft substitute and autograft extender in an ovine distal femoral critical defect model.
    Hutchens SA; Campion C; Assad M; Chagnon M; Hing KA
    J Mater Sci Mater Med; 2016 Jan; 27(1):20. PubMed ID: 26684617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion.
    Jenis LG; Banco RJ
    Spine (Phila Pa 1976); 2010 Sep; 35(20):E1058-63. PubMed ID: 20479699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Two Synthetic Bone Graft Products in a Rabbit Posterolateral Fusion Model.
    Fredericks D; Petersen EB; Watson N; Grosland N; Gibson-Corley K; Smucker J
    Iowa Orthop J; 2016; 36():167-73. PubMed ID: 27528855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.